Correlation Between Blueprint Medicines and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and X4 Pharmaceuticals, you can compare the effects of market volatilities on Blueprint Medicines and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and X4 Pharmaceuticals.
Diversification Opportunities for Blueprint Medicines and X4 Pharmaceuticals
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Blueprint and XFOR is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Blueprint Medicines and X4 Pharmaceuticals
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.2 times more return on investment than X4 Pharmaceuticals. However, Blueprint Medicines Corp is 5.12 times less risky than X4 Pharmaceuticals. It trades about 0.2 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 8,277 in Blueprint Medicines Corp on August 29, 2024 and sell it today you would earn a total of 1,186 from holding Blueprint Medicines Corp or generate 14.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Blueprint Medicines Corp |
| X4 Pharmaceuticals |
Blueprint Medicines and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and X4 Pharmaceuticals
The main advantage of trading using opposite Blueprint Medicines and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |